GSA Capital Partners’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,128
| Closed | -$33K | – | 1962 |
|
|
2022
Q1 | $33K | Sell |
4,128
-10,530
| -72% | -$84.2K | ﹤0.01% | 1350 |
|
|
2021
Q4 | $195K | Sell |
14,658
-11,625
| -44% | -$155K | 0.02% | 1238 |
|
|
2021
Q3 | $1.15M | Buy |
26,283
+20,877
| +386% | +$910K | 0.12% | 240 |
|
|
2021
Q2 | $226K | Buy |
5,406
+4,877
| +922% | +$204K | 0.03% | 1123 |
|
|
2021
Q1 | $26K | Sell |
529
-194
| -27% | -$9.54K | ﹤0.01% | 1046 |
|
|
2020
Q4 | $71K | Sell |
723
-7,042
| -91% | -$692K | 0.01% | 1125 |
|
|
2020
Q3 | $536K | Buy |
7,765
+5,595
| +258% | +$386K | 0.09% | 349 |
|
|
2020
Q2 | $229K | Buy |
+2,170
| New | +$229K | 0.13% | 281 |
|
|
2018
Q2 | – | Sell |
-4,063
| Closed | -$512K | – | 2017 |
|
|
2018
Q1 | $512K | Buy |
+4,063
| New | +$512K | 0.03% | 1049 |
|
|
2017
Q4 | – | Sell |
-1,513
| Closed | -$477K | – | 1903 |
|
|
2017
Q3 | $477K | Sell |
1,513
-2,555
| -63% | -$806K | 0.03% | 1001 |
|
|
2017
Q2 | $1.21M | Buy |
4,068
+2,651
| +187% | +$787K | 0.08% | 419 |
|
|
2017
Q1 | $327K | Buy |
+1,417
| New | +$327K | 0.02% | 1330 |
|
|
2016
Q3 | – | Sell |
-2,190
| Closed | -$162K | – | 2040 |
|
|
2016
Q2 | $162K | Buy |
2,190
+450
| +26% | +$33.3K | 0.01% | 1618 |
|
|
2016
Q1 | $198K | Buy |
+1,740
| New | +$198K | 0.01% | 1496 |
|